Skip to Main Content

Paper Details

Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
Clin Cardiol
2
2022
CV disease, DPP-4, HHF, MACE, Sitagliptin, TECOS, dipeptidyl peptidase 4, dipeptidyl peptidase-4, heart failure, patients, person, sitagliptin, type 2 diabetes
Author NameAffiliation
Benjamin M SciricaBrigham and Women's Hospital and Harvard Medical School
Marc S SabatineBrigham and Women's Hospital and Harvard Medical School
Marc S SabatineBrigham and Women's Hospital and Harvard Medical School
  • 1 - 3

Datasets

Release 1.2